Table 1.

Human samples

Patient	Gender	Age	Clinical diagnosis	Region	Fixative
Q1010	Male	30	Epilepsy	Anterior lateral temporal cortex	2% PFA, 2% GA in PB
Q1011	Male	44	Epilepsy	Anterior medial temporal cortex	4% PFA, 1% GA, 2.5% DMSO in PB
Q1014	Female	48	Epilepsy	Anterior lateral temporal cortex	2% PFA, 4% GA, 2.5% DMSO in CB
Q1015	Female	66	Epilepsy	Anterior lateral temporal cortex	2% PFA, 4% GA, 2.5% DMSO in CB
Q1016	Male	49	Epilepsy	Lateral temporal cortex	2% PFA, 4% GA, 2.5% DMSO in CB
Q1017	Male	46	Epilepsy	Lateral temporal cortex	2% PFA, 4% GA, 2.5% DMSO in CB
Q1018	Female	20	Epilepsy	Lateral temporal cortex	2% PFA, 4% GA, 2.5% DMSO in CB
Q1019	Female	51	Epilepsy	Lateral temporal cortex	2% PFA, 4% GA, 2.5% DMSO in CB
10/16/14	Female	30	Nonspecific inflammation of the white matter	Frontal cortex	4% PFA in PB

CB, cacodylate buffer; DMSO, dimethyl sulfoxide; GA, glutaraldehyde; PB, phosphate buffer; PFA, paraformaldehyde.